Product Overview
Structure
1 bottle contains:
Active substances:
Phospholipids (Lipoid C 100) - 0.50 g
Glycyrrhizic acid trisodium salt (sodium glycyrrhizinate) - 0.20 g
Excipient:
Maltose - 1.80 g
pharmachologic effect
Combined remedy.
It has a membrane stabilizing, hepatoprotective and antiviral effect.
Phosphatidylcholine (the main component of phospholipids) is the main structural element of cell and intracellular membranes; it is able to restore their structure and function upon damage, having a cytoprotective effect.
It normalizes protein and lipid metabolism, prevents the loss of enzymes and other active substances by hepatocytes, restores liver function, inhibits the formation of connective tissue, reducing the risk of liver fibrosis and cirrhosis.
Glycyrrhizic acid has an anti-inflammatory effect, inhibits the reproduction of viruses in the liver and other organs by stimulating the production of interferons, increasing phagocytosis, and increasing the activity of natural killer cells.
It has a hepatoprotective effect due to antioxidant and membrane stabilizing activity. Glycyrrhizic acid potentiates the action of endogenous glucocorticosteroids, providing anti-inflammatory and anti-allergic effects in non-infectious liver lesions.
With skin lesions due to the membrane-stabilizing and anti-inflammatory action of the components, it limits the spread of the process and contributes to the regression of the disease.
Indications
Viral hepatitis (acute and chronic), fatty liver degeneration (hepatosis), other liver lesions (drug, alcohol, toxic), cirrhosis, intoxication, psoriasis, neurodermatitis, eczema.
Contraindications
Hypersensitivity to the components of the drug, pregnancy, lactation, children's age up to 12 years.
Side effects
With increased individual sensitivity, a skin rash may occur, which disappears after discontinuation of the drug.
Interaction
The contents of the vial should not be mixed with other solutions.
It is forbidden to use saline or glucose solution for dilution of the drug.
How to take, course of administration and dosage
The injection solution is administered intravenously after dissolving 2.5 g (1 bottle) of dry lyophilized powder in 10 ml of pyrogen-free water (water for injection).
In the acute form of the disease, the drug is administered 1 or 2 times a day for 10-30 days, in the chronic form 1 time every other day or 3 times a week for 6-12 months.
After the end of the intravenous course, therapy can be continued with Phosphogliv in capsules - 2 capsules 3 times a day for 30 days in acute and 6-12 months in the chronic form of the disease.
Release form
Lyophilisate for the preparation of a solution for iv administration
